392 related articles for article (PubMed ID: 27955878)
1. Prevalence and Predictive Value of BI-RADS 3, 4, and 5 Lesions Detected on Breast MRI: Correlation with Study Indication.
Chikarmane SA; Tai R; Meyer JE; Giess CS
Acad Radiol; 2017 Apr; 24(4):435-441. PubMed ID: 27955878
[TBL] [Abstract][Full Text] [Related]
2. An Abbreviated Protocol for High-risk Screening Breast Magnetic Resonance Imaging: Impact on Performance Metrics and BI-RADS Assessment.
Panigrahi B; Mullen L; Falomo E; Panigrahi B; Harvey S
Acad Radiol; 2017 Sep; 24(9):1132-1138. PubMed ID: 28506511
[TBL] [Abstract][Full Text] [Related]
3. Screening Breast MRI Outcomes in Routine Clinical Practice: Comparison to BI-RADS Benchmarks.
Strigel RM; Rollenhagen J; Burnside ES; Elezaby M; Fowler AM; Kelcz F; Salkowski L; DeMartini WB
Acad Radiol; 2017 Apr; 24(4):411-417. PubMed ID: 27986508
[TBL] [Abstract][Full Text] [Related]
4. Breast MRI BI-RADS assessments and abnormal interpretation rates by clinical indication in US community practices.
Lee CI; Ichikawa L; Rochelle MC; Kerlikowske K; Miglioretti DL; Sprague BL; DeMartini WB; Wernli KJ; Joe BN; Yankaskas BC; Lehman CD
Acad Radiol; 2014 Nov; 21(11):1370-6. PubMed ID: 25126973
[TBL] [Abstract][Full Text] [Related]
5. Improving outcomes of screening breast MRI with practice evolution: initial clinical experience with 3T compared to 1.5T.
Lourenco AP; Donegan L; Khalil H; Mainiero MB
J Magn Reson Imaging; 2014 Mar; 39(3):535-9. PubMed ID: 23720144
[TBL] [Abstract][Full Text] [Related]
6. BI-RADS Category 5 Assessments at Diagnostic Breast Imaging:Outcomes Analysis Based on Lesion Descriptors.
Yao MM; Joe BN; Sickles EA; Lee CS
Acad Radiol; 2019 Aug; 26(8):1048-1052. PubMed ID: 30195413
[TBL] [Abstract][Full Text] [Related]
7. Utility of BI-RADS Assessment Category 4 Subdivisions for Screening Breast MRI.
Strigel RM; Burnside ES; Elezaby M; Fowler AM; Kelcz F; Salkowski LR; DeMartini WB
AJR Am J Roentgenol; 2017 Jun; 208(6):1392-1399. PubMed ID: 28792802
[TBL] [Abstract][Full Text] [Related]
8. Characteristics, Malignancy Rate, and Follow-up of BI-RADS Category 3 Lesions Identified at Breast MR Imaging: Implications for MR Image Interpretation and Management.
Chikarmane SA; Birdwell RL; Poole PS; Sippo DA; Giess CS
Radiology; 2016 Sep; 280(3):707-15. PubMed ID: 27089027
[TBL] [Abstract][Full Text] [Related]
9. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
Cilotti A; Iacconi C; Marini C; Moretti M; Mazzotta D; Traino C; Naccarato AG; Piagneri V; Giaconi C; Bevilacqua G; Bartolozzi C
Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
[TBL] [Abstract][Full Text] [Related]
10. Screening breast MR imaging: comparison of interpretation of baseline and annual follow-up studies.
Abramovici G; Mainiero MB
Radiology; 2011 Apr; 259(1):85-91. PubMed ID: 21285337
[TBL] [Abstract][Full Text] [Related]
11. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?
Uematsu T; Yuen S; Kasami M; Uchida Y
Breast Cancer Res Treat; 2007 Jul; 103(3):269-81. PubMed ID: 17063274
[TBL] [Abstract][Full Text] [Related]
12. Probably benign breast MRI lesions: frequency, lesion type, and rate of malignancy.
Lourenco AP; Chung MT; Mainiero MB
J Magn Reson Imaging; 2014 Apr; 39(4):789-94. PubMed ID: 24108546
[TBL] [Abstract][Full Text] [Related]
13. Maximum intensity breast diffusion MRI for BI-RADS 4 lesions detected on X-ray mammography.
Bickelhaupt S; Paech D; Laun FB; Steudle F; Kuder TA; Mlynarska A; Bach M; Lederer W; Teiner S; Schneider S; Ladd ME; Daniel H; Stieber A; Kopp-Schneider A; Delorme S; Schlemmer HP
Clin Radiol; 2017 Oct; 72(10):900.e1-900.e8. PubMed ID: 28687167
[TBL] [Abstract][Full Text] [Related]
14. Breast MRI as an adjunct to mammography: Does it really suffer from low specificity? A retrospective analysis stratified by mammographic BI-RADS classes.
Benndorf M; Baltzer PA; Vag T; Gajda M; Runnebaum IB; Kaiser WA
Acta Radiol; 2010 Sep; 51(7):715-21. PubMed ID: 20707656
[TBL] [Abstract][Full Text] [Related]
15. Results of MR imaging screening for breast cancer in high-risk patients with lobular carcinoma in situ.
Friedlander LC; Roth SO; Gavenonis SC
Radiology; 2011 Nov; 261(2):421-7. PubMed ID: 21900618
[TBL] [Abstract][Full Text] [Related]
16. Screening Breast MRI in Patients Previously Treated for Breast Cancer: Diagnostic Yield for Cancer and Abnormal Interpretation Rate.
Giess CS; Poole PS; Chikarmane SA; Sippo DA; Birdwell RL
Acad Radiol; 2015 Nov; 22(11):1331-7. PubMed ID: 26142951
[TBL] [Abstract][Full Text] [Related]
17. Tomosynthesis in the Diagnostic Setting: Changing Rates of BI-RADS Final Assessment over Time.
Raghu M; Durand MA; Andrejeva L; Goehler A; Michalski MH; Geisel JL; Hooley RJ; Horvath LJ; Butler R; Forman HP; Philpotts LE
Radiology; 2016 Oct; 281(1):54-61. PubMed ID: 27139264
[TBL] [Abstract][Full Text] [Related]
18. Predictive values of BI-RADS(®) magnetic resonance imaging (MRI) in the detection of breast ductal carcinoma in situ (DCIS).
Badan GM; Piato S; Roveda D; de Faria Castro Fleury E
Eur J Radiol; 2016 Oct; 85(10):1701-1707. PubMed ID: 27666605
[TBL] [Abstract][Full Text] [Related]
19. Focal Breast Lesions in Clinical CT Examinations of the Chest: A Retrospective Analysis.
Krug KB; Houbois C; Grinstein O; Borggrefe J; Puesken M; Hanstein B; Malter W; Maintz D; Hellmich M
Rofo; 2017 Oct; 189(10):977-989. PubMed ID: 28683503
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
